Literature DB >> 33910852

Myocardial Fibrosis as a Predictor of Ventricular Arrhythmias in Patients With Non-ischemic Cardiomyopathy.

Călin Schiau1, Daniel-Corneliu Leucuța2, Sorin Marian Dudea1, Simona Manole1.   

Abstract

BACKGROUND/AIM: The aim of the study was to assess the relationship between myocardial fibrosis characteristics (percentage, localization, heterogeneity), evaluated by a non-invasive method such as cardiac magnetic resonance (CMR), with the extrasystolic ventricular arrhythmia in patients with non-ischemic cardiomyopathy. PATIENTS AND METHODS: The study prospectively included 173 consecutive patients who underwent electrocardiogram Holter monitoring, transthoracic echocardiography and CMR with late gadolinium enhancement (LGE).
RESULTS: In univariate analysis, both the presence (OR=1.05, 95% CI=1.01-1.09; p=0.015), the percentage of fibrosis >15% (p=0.018), the septum size, the fibrosis in either lateral or septal walls (p=0.004), as well as fibrosis in the midwall (p=0.019) were statistically significant higher in the group with extrasystolic arrhythmia. After adjustment, the percentage of fibrosis >15%, had higher odds of extra systolic arrhythmia [OR=3.78 (95% CI=1.52-10.62, p=0.007)].
CONCLUSION: The presence, percentage, and localisation of left ventricle myocardial fibrosis characterized by LGE-CMR was associated with ventricular arrhythmias. Copyright
© 2021, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  CMR; Implantable cardioverter-defibrillator; Sudden cardiac death; non-ischemic Cardiomyopathy

Mesh:

Substances:

Year:  2021        PMID: 33910852      PMCID: PMC8193320          DOI: 10.21873/invivo.12427

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  26 in total

1.  An improved MR imaging technique for the visualization of myocardial infarction.

Authors:  O P Simonetti; R J Kim; D S Fieno; H B Hillenbrand; E Wu; J M Bundy; J P Finn; R M Judd
Journal:  Radiology       Date:  2001-01       Impact factor: 11.105

2.  Evaluation of techniques for the quantification of myocardial scar of differing etiology using cardiac magnetic resonance.

Authors:  Andrew S Flett; Jonathan Hasleton; Christopher Cook; Derek Hausenloy; Giovanni Quarta; Cono Ariti; Vivek Muthurangu; James C Moon
Journal:  JACC Cardiovasc Imaging       Date:  2011-02

3.  Myocardial scar visualized by cardiovascular magnetic resonance imaging predicts major adverse events in patients with hypertrophic cardiomyopathy.

Authors:  Oliver Bruder; Anja Wagner; Christoph J Jensen; Steffen Schneider; Peter Ong; Eva-Maria Kispert; Kai Nassenstein; Thomas Schlosser; Georg V Sabin; Udo Sechtem; Heiko Mahrholdt
Journal:  J Am Coll Cardiol       Date:  2010-06-25       Impact factor: 24.094

4.  Prognostic value of quantitative contrast-enhanced cardiovascular magnetic resonance for the evaluation of sudden death risk in patients with hypertrophic cardiomyopathy.

Authors:  Raymond H Chan; Barry J Maron; Iacopo Olivotto; Michael J Pencina; Gabriele Egidy Assenza; Tammy Haas; John R Lesser; Christiane Gruner; Andrew M Crean; Harry Rakowski; James E Udelson; Ethan Rowin; Massimo Lombardi; Franco Cecchi; Benedetta Tomberli; Paolo Spirito; Francesco Formisano; Elena Biagini; Claudio Rapezzi; Carlo Nicola De Cecco; Camillo Autore; E Francis Cook; Susie N Hong; C Michael Gibson; Warren J Manning; Evan Appelbaum; Martin S Maron
Journal:  Circulation       Date:  2014-08-05       Impact factor: 29.690

Review 5.  Myocardial Fibrosis Assessment by LGE Is a Powerful Predictor of Ventricular Tachyarrhythmias in Ischemic and Nonischemic LV Dysfunction: A Meta-Analysis.

Authors:  Marcello Disertori; Marta Rigoni; Nicola Pace; Giancarlo Casolo; Michela Masè; Lucio Gonzini; Donata Lucci; Giandomenico Nollo; Flavia Ravelli
Journal:  JACC Cardiovasc Imaging       Date:  2016-07-20

6.  Assessment of myocardial scarring improves risk stratification in patients evaluated for cardiac defibrillator implantation.

Authors:  Igor Klem; Jonathan W Weinsaft; Tristram D Bahnson; Don Hegland; Han W Kim; Brenda Hayes; Michele A Parker; Robert M Judd; Raymond J Kim
Journal:  J Am Coll Cardiol       Date:  2012-07-31       Impact factor: 24.094

Review 7.  Systematic review: implantable cardioverter defibrillators for adults with left ventricular systolic dysfunction.

Authors:  Justin A Ezekowitz; Brian H Rowe; Donna M Dryden; Nicola Hooton; Ben Vandermeer; Carol Spooner; Finlay A McAlister
Journal:  Ann Intern Med       Date:  2007-08-21       Impact factor: 25.391

8.  Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy.

Authors:  Frank Grothues; Gillian C Smith; James C C Moon; Nicholas G Bellenger; Peter Collins; Helmut U Klein; Dudley J Pennell
Journal:  Am J Cardiol       Date:  2002-07-01       Impact factor: 2.778

9.  Left ventricular ejection fraction normalization in cardiac resynchronization therapy and risk of ventricular arrhythmias and clinical outcomes: results from the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy (MADIT-CRT) trial.

Authors:  Martin H Ruwald; Scott D Solomon; Elyse Foster; Valentina Kutyifa; Anne-Christine Ruwald; Saadia Sherazi; Scott McNitt; Christian Jons; Arthur J Moss; Wojciech Zareba
Journal:  Circulation       Date:  2014-10-09       Impact factor: 29.690

Review 10.  Cardiovascular magnetic resonance: contribution to the exploration of cardiomyopathies.

Authors:  Călin Schiau; Şerban Schiau; Sorin M Dudea; Simona Manole
Journal:  Med Pharm Rep       Date:  2019-10-25
View more
  1 in total

1.  Correlation between Volumes Determined by Echocardiography and Cardiac MRI in Controls and Atrial Fibrillation Patients.

Authors:  Simona Manole; Claudia Budurea; Sorin Pop; Alin M Iliescu; Cristiana A Ciortea; Stefania D Iancu; Loredana Popa; Mihaela Coman; László Szabó; Vasile Coman; Zoltán Bálint
Journal:  Life (Basel)       Date:  2021-12-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.